Gilead Sciences, Inc. collaborates with Jounce Therapeutics, Inc., focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers... Sep 02
The collaboration excludes Tango’s lead programs, including one program that is expected to be in investigational new drug (IND) applicatation-enabling studies next year... Aug 19
-Advertisements-